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Summary.-The response of multicellular tumour spheroids of the EMT6 cell line
to combinations of hyperthermia and Bleomycin (BLM) or Adriamycin (ADM) has
been investigated. Using this model system, we have demonstrated enhanced BLM
cytotoxicity at 43°C and also heat-induced drug tolerance to BLM at 43°C. ADM cyto-
toxicity was not significantly increased after 43°C x 1 h but after 6 h at 42°C greatly
enhanced cell-killing was evident. These results are discussed in relation to our
previous data for EMT6 cells growing either as monolayer cultures in vitro or as
solid tumours in mice.
MULTICELLULAR TUMOUR SPHEROIDS are
a useful in vitro model system possessing
many characteristics of in vivo tumours
not present in monolayer cultures (Suther-
land & Durand, 1976). The response of
spheroids derived from various tumour-
cell lines to hyperthermia has been
described by several workers. V79 spher-
oids have been shown to be less sensitive
to hyperthermia than single cells, thermo-
resistance increasing with spheroid size
(Durand, 1975). Differential heat-killing
across the spheroid has been reported bv
Sutherland (1975), the central cells being
nmore sensitive to hyperthermia. Also,
hyperthermia has been shown to enhance
radiation damage (Durand, 1975; Lucke-
Huihle & Dertinger, 1977) and to increase
the cytotoxicity of misonidazole (Sridhar
& Sutherland, 1977) in this system. A
marked resistance of EMT6/Ro spheroids
to Adriamycin (ADM) in comparison with
exponentially growing monolayer cells has
been demonstrated by Sutherland et al.
(1979). They have also shown, by fluores-
cence microscopy, a gradient in the ADM
concentration from peripheral to central
regions of the spheroid, drug penetration
to the inner cells being poor even at high
external concentrations of ADM.
Hyperthermia ha,s been shown to en-
hance markedly the cytotoxicity of some
drugs commonly used as anticancer agents
(review by Field & Bleehen, 1 979). For
exponentially growing monolayer cultures
of the EMT6 cell line we have previously
demonstrated a significant increase in
Bleomycin (BLM) and BCNU cytotoxicity
at 43°C. Preheating, to 40°C( was fouind to
induce tolerance to these druigs at 43°C.
No enhanced cytotoxicity was seen for
ADM at 43°C, and this response was tin-
affected by the preheat treatment (Morgan
et al., 1.979).
This paper describes the response of
multicellular tumouir spheroids of the
EMT6 cell line to the combination of
hyperthermia and cytotoxic (Irugs.
MATERIALS AND METHOI)S
Spheroids. Multicellular tumiour spheroids
weore growi-n according to the metlhods de-
scribed by Yuhas et al. (1977). Full details of
the EMT6/Ca/XTJAC spheroid system as used
in our laboratory are described by TwN-enty-
man (1980). Briefly, spheroids wN-ere grown
from 5 x 105 cells introduced as a single-cell
suspension into a 75cm1'2 culture flask base-
coated with agar to prevent cell aldhesion to
the plastic surface. By Day 6 the spheroids
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aliquots of spheroids were transferred into a
series of experimental flasks (25cm2 plastic
flasks base-coated with agar) each containing
a total of 5 ml medium (Eagle's MEM+ 10%
foetal calf serum). Drug was then added to
give the required concentration in 5 ml.
Heat treatment.-All 37°C treatments were
carried out in a 37°C incubator. Heating was
by means oftotal immersion ofthe flasks into
a circulating waterbath with the temperature
controlled to +010C (Grant Ltd, U.K.).
Measurements within the flasks with insu-
lated thermistor probes showed that they
equilibrated with the waterbath temperatures
within 5-10 min of immersion. In the experi-
ments involving preheating at 40°C, this was
always carried out in the absence of any
added drug. After the preheating, drug was
introduced before transferring the flasks to
37°C or 43TC.
Assay methods.-After treatment the spher-
oids were removed from the flask and washed
in fresh medium. Twelve representative
spheroids were then selected from each treat-
ment group and placed in individual wells on
plastic multidishes, each containing 1 ml
medium over 0-5 ml agar (0.75%) for re-
growth studies. An eyepiece graticule was
used to record 2 perpendicular diameters for
each spheroid every 2 days, and these meas-
urements were used to calculate the growth
delay for each treatment group. The remain-
ing spheroids from each group were washed
with 5 ml 0.075% trypsin in a plastic univer-
sal container and then incubated at 37TC in
an excess of trypsin for 15 min. The univer-
sals were then centrifuged at 1000 rev/min
(170 g) for 5 min and the cell pellet was re-
suspended in 1-5 ml medium. The cell suspen-
sion was then assayed for surviving fraction
as has been described by Twentyman (1980).
Drugs.-The drugs used in these experi-
ments were:
(1) Bleomycin (BLM, Lundbeck) obtained
as a freeze-dried 15mg plug. This was dis-
solved in Hanks' Balanced Salt Solution
(HBSS), diluted to 2-5 mg/ml and stored at
-20°C in small aliquots. Each aliquot was
thawed at 37°C and further diluted with
HBSS before use.
(2) Adriamycin (ADM: doxorubicin HCI,
Pharmitalia) obtained as 10 mg freeze-dried
powder with lactose. This was dissolved in
HBSS, diluted to 250 mug/ml and stored at
-20°C. Before use, an aliquot was thawed at
37°C and further diluted with HBSS.
Analysis of results.-For a first analysis of
the regrowth data, mean spheroid diameter
for each treatment group was plotted against
time after treatment. This enabled com-
parison between the regrowth curves of the
different treatment groups within an experi-
ment. However, for a more detailed analysis
of the results, individual regrowth plots were
used to calculate the time taken to reach
4 times the original spheroid volume (the
endpoint used in these particular studies, as
by this time the treated groups have essenti-
ally assumed the growth characteristics of
control spheroids). The geometric mean times
were then calculated for both groups and from
these data the growth delay with its 95%
confidence limits was obtained for the experi-
mental group. In some groups a small number
of spheroids failed to regrow to the endpoint
volume during the course of the experiment
(generally about 3 weeks) and these spheroids
were omitted from the subsequent statistical
analysis. Such spheroids were always found
in groups given heat together with high-dose
BLM, where the surviving fraction was re-
duced to around 0 5-2 0%. At the time of
treatment the spheroids were around 250 ,um
in diameter, with an outer rim of dividing
cells surrounding an inner non-proliferating
population of cells. It is known that such
spheroids contain 2-5 x 103 clonogenic cells.
Therefore, at a survival level of 1.0% there
are only on average 20-50 viable cells per
spheroid. So, depending on the location ofthe
surviving cells, it is possible that some of the
spheroids at the lower end of this survival
range will not regrow in 20 days. Over the
range of spheroid size used in these experi-
ments (200-300 ,um in diameter) failure to
regrow did not appear to be related to the
original size ofthe spheroid.
RESIULTS
Fig. 1 shows cell-survival data for
spheroids disaggregated immediately after
exposure to BLM for 1 h at 37°C and 43TC.
The cytotoxicity of BLM at 43°C can be
seen to be significantly enhanced at all
drug doses.
In Fig. 2, mean spheroid diameter has
been plotted against days after treatment
for 4 different groups of spheroids. From
these data it is possible to see that,
whereas heat alone and BLM at 37°C only
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produced relatively small changes in the
regrowth pattern compared to that of
control spheroids, BLM at 43°C produced
a much greater growth retardation. A
more detailed analysis of these data based
on the regrowth of individual spheroids is
shown in Fig. 3. A significant increase in
growth delay can be seen at 43°C for all
concentrations of BLM. For example,
with 20 ,tg/ml BLM a growth delay of 0*9
(0.4-1.5) days at 37°C x h was enhanced
to 5-7 (5.0-6.5) days at 430C x I h. This
latter group included one spheroid which
had not regrown in 20 days and was there-
fore excluded from the calculation of
growth delay.
Estimations of cell survival from experi-
ments in which spheroids were preheated
at 40TC for 6 h before BLM exposure at
43°Cx 1 h are shown in Fig. 4. For
spheroids treated with heat alone, pre-
heating produced no detectable changes in
the heat response at 43°C. However, these
data provide some evidence of induced
tolerance to BLM cytotoxicity as a result
of the preheat treatment, but only signifi-
cantly at high drug doses. Similar trends
can be seen in the regrowth data from this
series of experiments. The growth delays
with 950% confidence limits for the heat-
alone spheroids were 0 3 (0.1-0.5) days for
preheated and 0*5 (0.3-0.7) days for non-
preheated spheroids. Twenty Hug/ml BLM
for 37°C x 1 h produced a growth delay of
1.2 (0.5-1.9) days, and at 43'C this was
enhanced to 5*9 (4. -7.7) days. The latter
group included 2 spheroids which did not
regrow to the endpoint volume in 20 days,
and were therefore omitted from the
statistical analysis. Heating for 6 h at
40°C produced no significant, growth delay.
However, wvhen this treatment preceded
20 ug/ml BLM at 43°C x 1 h the growth
delay was reduced to 3*2 (2.4-3 9) days.
Fig. 5 shows cell-survival data for
spheroids disaggregated immediately after
exposure to ADM for 1 h at 37°C and 430(1.
Although the surviving fractions for
spheroids treated at 43°C appear to be
lower at, all drug doses, this reduction is
not significantly greater than that ex-
pected from the independent action of the
heat and drug treatments. This lack of
enhanced ADM killing after heating at
43°C x I h is also reflected in the growth-
delay data for these experimentts, a typical
example of which is shown in Fig. 6. The
Table summarizes the growth delay data
from this experiment for 2 doses of ADAI.
Similar trends were seen in replicate
experiments.
Prolonged exposure at 420C' has been
shown to significantly enhance ADM cyto-
toxicity, whether the response of the
spheroids was assayed in terms of sur-
viving fraction or growtlh delay. Growtih-
delay data calculated from a typical set of
results is shown in Fig. 7. Short exposures
A
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FIG. 2. Growth curves from a typical experiment in which EMT6 spheroids were treated with BLM
on Day 0. Each point represents the mean spheroid diameter from groups of 8-12 spheroids and
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FIG. 3.-Growth delays calculated from the
results of a typical experiment for EMT6
spheroids treated with BLM for 1 h at
37°C (0) and 43°C (0). Error bars rep-
resent the 95% confidence limits.
can be seen to produce no significant in-
crease in ADM cytotoxicity at 42'C, but
after 6 h the growth delay of 1*0 (0.6-1-5)
days at 37°C is enhanced to 4-5 (2.6-5.7)
days at 42°C. Heat alone for 6 h produced
a growth delay of 0*8 (0.6-1.0) days.
DISCUSSION
In these studies multicellular tumour
spheroids have been used as a relatively
sophisticated in vitro model system to
investigate the response to combinations
ofhyperthermia and cytotoxic drugs. This
system has several advantages over con-
ventional in vitro cultures forexperiments
involving interactions between heat and
drugs. In particular, the response to treat-
ment can be estimated in terms of 2 end-
points: regrowth delay and surviving
fraction. A comparison between these end-
points may therefore help to eliminate any
artefacts introduced into the estimations
of surviving fraction through spheroid
disaggregation with trypsin. This factor
may be particularly important in treat-
ments involving membrane damage.
Although the mechanisms producing cell
death after hyperthermia still remain to
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FIG. 4.-The effect of a 6h pretreatment at
40°C on the subsequent response of EMT6
spheroids to BLM at 43°C for 1 h. Points
represent data from a series of replicate
experiments. *, 1 h 430C+BLM. *, 6 h
40'C- 1 h 430C +BLM.
be fully elucidated, various theories over
the last few years have suggested that the
cell membrane is a primary target for heat
damage (Bowler et al., 1973; Yatvin,
1977).
Growth delay is also a useful endpoint
for experiments in which the time of assay
after treatment is important. With some
drug treatments there is considerable
repair of potentially lethal damage over
the 24 h after treatment, and in such cases
assay of surviving fraction immediately
after treatment will lead to artificially low
estimations of cell survival (Twentyman,
1980). Such phenomena are avoided in the
regrowth assay.
As in the regrowth of solid tumours
Treatment for 1 h
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FIG. 5.-The effect on the cell survival of
EMT6 spheroids of exposure to ADM for
1 h at 37°C (0) and 43°C (0). SF assayed
immediately after treatment. Data points
from a series of replicate experiments.
after treatment, the factors involved in
determining the growth delay ofa spheroid
include cell kill, cell-cyee delay and cell
repopulation. The, relative importance of
each of these factors will vary from one
treatment to another. For example, for lh
exposures to graded doses ofADM at 37°C
or 43°C, long growth delays are seen at
relatively low levels of cell killing. From
these data, doubling times around 48 h
have been calculated, compared to 12-14 h
in control spheroids. However, with pro-
longed ADM exposure at 42°C there is a
less marked increase in cell-cycle time, but
for a given growth delay a greater cell kill
is seen.
In spite of these considerations, the
conclusions drawn from these studies are
the same whether the response to treat-
ment was assayed in terms of cell survival
TABLE.-Growth delay calculated from the
results of a typical experiment in which
EMT6 spheroids were treated with 2 doses
of ADMfor 1 h at 370C or 430C
10- I z
0
v)
LI.
z 5:
U) 16-2
388
Ak- L_
,ftRESPONSE OF EMT6 SPHEROIDS TO HYPERTHERMIA AND DRUGS
800
E
LU 600
< 0
00) 2 ' 6 * 8 * 10 * 12 * 14
DAYS AFTER TREATMENT
FIG. 6.- Regrowth curves from a typical experiment in which EMT6 spheroids were treated on Day 0.
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FIG. 7. Growth delay calculated from the
results of a typical experiment in which
EMT6 spheroids were treated with ADM
at 37°C and 42°C. Error bars represent the
95% confidence limits. A, 42°C alone.
0, 37°C + 1 ,ug/ml ADM. 0, 42°C + 1 jg/ml
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or regrowth parameters. In summary,
ADM cytotoxicity was not significantly
increased after 4300 x 1 h, but after 6 h at
4200 greatly enhanced cell-killing was
evident. We have also shown enhanced
BLM cytotoxicity at 43°C and heat-
induced drug tolerance to BLM at 4300.
These results are therefore very similar to
our previous data for EMT6 cells growing
as monolayer cultures (Morgan et al.,
1979). Here, we reported that preheating
at temperatures of 39-41°C induced ther-
mal tolerance and also tolerance to BLM
at 430C while not affecting its cytotoxicity
at 3700. However, a limited series of in
vivo experiments in which the solid
EMT6 tumour was heated by immersion
in a circulating waterbath at 43°C showed
no evidence ofeither increased BLM cyto-
toxicity or of BLM tolerance after pre-
heating at 400C (Morgan & Bleehen, 1981).
These in vivo results however show some
discrepancies with those from other
laboratories. Hahn et al. (1975) reported
the enhanced BLM cytotoxicity seen under
in vitro conditions also to be present in
their solid tumour system in vivo. We have
no explanation for these differences at this
time. However, the lack of enhanced
BLM cytotoxicity in vivo may be related
U
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to non-uniformity oftemperature through-
out the tumour, which is a common prob-
lem associated with waterbath heating.
We have previously demonstrated both a
temperature gradient between tumour
and waterbath and also a temperature
difference of up to 06°C between central
and peripheral regions for the same
tumour (Bleehen et al., 1977). These
temperature differences will be particu-
larly important in experiments combining
hyperthermia with cytotoxic drugs which
show temperature threshold effects. For
both BLM and ADM there appears to be
a temperature threshold of around 43°C
before there is a major potentiation of
drug cytotoxicity (Hahn et al., 1975; Hahn
& Strande, 1976).
In these spheroid studies we have
shown a significant enhancement of BLM
cytotoxicity after 43°C x 1 h. This is
thought to be related to the hyperthermic
inhibition of repair mechanisms, and
Meyn et al. (1979) have shown that the
repair ofBLM-induced DNA strand breaks
important to cell survival is prevented at
43°C. However, ADM-increased cell killing
was only observed after heating for more
than 4 h at 420C or 42-5CC. Exposure to
1 ,ug/ml ADM for up to 3 h at 43°C did not
significantly enhance cytotoxicity. Heat-
ing beyond 3 h was not possible, as cell
survival after heat alone reaches the limit
of detectability of the assay after this
time. Inhibition of repair mechanisms
cannot explain heat-induced ADM sensi-
tization, as there is no evidence of repair
over the 24 h after treatment. Hahn et al.
(1975) suggest that the sensitization to
ADM which they see at 430C may be due
to either changes in cell-membrane perme-
ability leading to increased ADM uptake
at 43°C or to inhibition of active drug
exclusion. Sutherland et al. (1979) have
reported that 600-1O000,tn diameter
EMT6 spheroids are markedly more re-
sistant to ADM than monolayer cultures
of the same cell line. They have shown in
fluorescence studies that this resistance is
related in part to the poor penetration of
ADM into the inner regions of the spher-
oid. This factor may therefore be import-
ant in explaining the lack of enhanced
ADM cytotoxicity reported here at short
heating times. Changes in membrane
permeability after prolonged heating may
help to explain the increased cytotoxicity
seen after 6 h at 42/42.5TC. At the present
time, however, we are unable to make any
meaningful estimations of drug penetra-
tion into spheroids at the ADM concentra-
tions used in these studies. With EMT6
monolayer cultures we have shown a
similar pattern of ADM cytotoxicity at
42TC. At 43TC, however, this system shows
some evidence of enhanced cell killing
after 1 tg/ml ADM for 3 h (unpublished
data). These results suggest that a time/
temperature threshold effect may be
involved in determining ADM cytotoxicity
in this system.
The spheroids used in these studies
were all of a small size (200-300m
diameter). Other workers have shown that
as spheroids increase in diameter, they
develop central necrosis, and the outer
rim of actively dividing cells surrounds an
inner shell of slowly or non-cycling cells.
An 02 gradient develops across the
spheroid and the necrotic centre may be
surrounded by a region ofradiobiologically
hypoxic cells (Sutherland & Durand,
1973). We are currently continuing these
investigations to study the significance of
these different cell populations in the
response of the spheroids to hyperthermia
and cytotoxic drugs.
We should like to thank L. S. Fr-ee(man for statis-
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